Neptune Technologies & Bioressources Inc.

CORRECTION FROM SOURCE: Neptune Reports Fiscal 2013 Results and Provides Update on Action Plan to Resume Operations

LAVAL, Quebec, May 22, 2013 (GLOBE NEWSWIRE) -- A correction from Source has been issued for the Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") release disseminated on May 22, 2013 at 8:49 a.m. ET. Once operational, the capacity of the Corporation's plant should read "more than 150,000 kilograms of krill oil per year" instead of "more than 150,000 metric tons of krill oil per year". A complete and corrected release follows.  

Neptune Technologies & Bioressources Inc.

Neptune Reports Fiscal 2013 Results and Provides Update on Action Plan to Resume Operations

LAVAL, Quebec, May 22, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces its consolidated financial results for the fourth quarter and fiscal year ended February 28, 2013 and provides update on action plan to resume operations.

Neptune Technologies & Bioressources Inc.

Neptune Responds to Aker's Continued Attempts to Deflect Attention From Its Sustained Patent Infringement

LAVAL, Quebec, May 15, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) announces that the United States Patent and Trademark Office ("USPTO") recently issued a

Neptune Technologies & Bioressources Inc.

Class Action Lawsuit Against Neptune Dismissed

LAVAL, Quebec, May 15, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that the previously announced class action lawsuit filed against Neptune and certain of its officers (the "defendants") on December 19, 2012 by Robbins Geller Rudman & Dowd LLP in the United States District Court for the Southern District of New York was voluntarily dismissed by the plaintiffs, without prejudice. No payment was made by any of the defendants in connection with the dismissal.  

Neptune Technologies & Bioressources Inc.

Neptune to Hold Conference Call to Discuss Fourth Quarter and Fiscal 2013 Results

LAVAL, Quebec, May 9, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("

Neptune Technologies & Bioressources Inc.

The U.S. International Trade Commission (ITC) Votes to Institute Patent Infringements Investigation Based on Neptune & Acasti Complaint

LAVAL, Quebec, April 15, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX:NTB) and Acasti Pharma Inc. ("Acasti") (Nasdaq:ACST) (TSX-V:APO), a Neptune subsidiary, announce that the U.S. International Trade Commission has voted to institute an investigation of alleged patent infringements by Aker BioMarine AS; Aker BioMarine Antarctic USA, Inc.; Aker BioMarine Antarctic AS; Enzymotec Limited; Enzymotec USA, Inc.; Olympic Seafood AS; Olympic Biotec Ltd.; Avoca, Inc.; Rimfrost USA, LLC and Bioriginal Food & Science Corp. (collectively the "Respondents").

Neptune Technologies & Bioressources Inc.

Neptune Provides Update on European Patent Dispute and Maintains Its International Patent Strategy

LAVAL, Quebec, April 10, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that it is moving forward with its international patent strategy and is not affected in any way by the recent action by the European Patent Office's Technical Appeal Board (the "Board") to dismiss Neptune's appeal related to one of its European patents, specifically EP 1417211. The Board was solely concerned with the issue of flavonoids in krill extracts. Importantly the Board did not address phospholipid compositions, which form a large part of Neptune's extensive international patent portfolio.

Neptune Technologies & Bioressources Inc.

Neptune to Present at the Annual ROTH Conference

LAVAL, Quebec, March 14, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("

Neptune Technologies & Bioressources Inc.

Neptune Obtains a Third U.S. Patent on Phospholipid Compositions, Further Bolstering Neptune's Request for an ITC Investigation

LAVAL, Quebec, Feb. 26, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("Neptune" or the "Corporation") (Nasdaq:NEPT) (TSX:NTB) announces that the U.S. Patent & Trademark Office (the "

Neptune Technologies & Bioressources Inc.

Neptune Responds to Aker BioMarine's Attempt to Shift the Focus From Neptune's Major ITC Filing

LAVAL, Quebec, Jan. 31, 2013 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. ("